JJ Case Continued: [NEW INFORMATION]: JJ was started on an ophthalmic prostaglandin analog after her first visit and has been compliant with therapy. At her 3 month follow-up visit her IOP has not yet reached the desired goal in her right eye. She does not have any additional new medical conditions. She and her eye care provider agree the next step will be to try dual pharmacologic therapy by adding_an agent with a different mechanism of action. Which is the most appropriate new ophthalmic therapy to add to her prior therapy at this time? a. netarsudil (Rhopressa) b. methazolamide oral C. timolol (Timoptic) d. dorzolamide (Trusopt) brimonidine (Alphagan P) e.
JJ Case Continued: [NEW INFORMATION]: JJ was started on an ophthalmic prostaglandin analog after her first visit and has been compliant with therapy. At her 3 month follow-up visit her IOP has not yet reached the desired goal in her right eye. She does not have any additional new medical conditions. She and her eye care provider agree the next step will be to try dual pharmacologic therapy by adding_an agent with a different mechanism of action. Which is the most appropriate new ophthalmic therapy to add to her prior therapy at this time? a. netarsudil (Rhopressa) b. methazolamide oral C. timolol (Timoptic) d. dorzolamide (Trusopt) brimonidine (Alphagan P) e.
Chapter19: Psychotropic Agents
Section: Chapter Questions
Problem 20RQ
Related questions
Question
![JJ Case Continued: [NEW INFORMATION]: JJ was started on an ophthalmic prostaglandin analog after
her first visit and has been compliant with therapy. At her 3 month follow-up visit her IOP has not yet
reached the desired goal in her right eye. She does not have any additional new medical conditions.
She and her eye care provider agree the next step will be to try dual pharmacologic therapy by adding an
agent with a different mechanism of action.
Which is the most appropriate new ophthalmic therapy to add to her prior therapy at this time?
a. netarsudil (Rhopressa)
b. methazolamide oral
C. timolol (Timoptic)
d. dorzolamide (Trusopt)
O e. brimonidine (Alphagan P)](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F4886508f-4429-44bc-b69f-0f40b6686249%2Ffe363506-3da3-4fd1-89b7-4521f62aa055%2F1spgett_processed.jpeg&w=3840&q=75)
Transcribed Image Text:JJ Case Continued: [NEW INFORMATION]: JJ was started on an ophthalmic prostaglandin analog after
her first visit and has been compliant with therapy. At her 3 month follow-up visit her IOP has not yet
reached the desired goal in her right eye. She does not have any additional new medical conditions.
She and her eye care provider agree the next step will be to try dual pharmacologic therapy by adding an
agent with a different mechanism of action.
Which is the most appropriate new ophthalmic therapy to add to her prior therapy at this time?
a. netarsudil (Rhopressa)
b. methazolamide oral
C. timolol (Timoptic)
d. dorzolamide (Trusopt)
O e. brimonidine (Alphagan P)
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 3 steps
Recommended textbooks for you